Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Paper in leading Journal

30 Nov 2018 07:00

RNS Number : 9782I
DeepMatter Group PLC
30 November 2018
 

30 November 2018

DeepMatter Group plc

("DeepMatter", or the "Group")

 

Publication of Paper in Science

 

DeepMatter, the AIM-listed company focusing on digitizing chemistry, announces that its founding scientific director, Professor Lee Cronin, and his colleagues at the University of Glasgow have today published a paper in Science, a leading international journal. DeepMatter has rights to intellectual property arising from the laboratory of Professor Cronin as part of its Intellectual Property and Royalty agreement with the University of Glasgow.

 

The paper describes for the first time a method of molecule production which uses downloadable 'blueprints' to easily and reliably synthesise chemicals, such as drug molecules, automatically via a programmable chemical-robot: a 'Chemputer'. The idea of the 'Chemputer' is underpinned by a universal and interoperable standard for writing and sharing chemical recipes, developed by the University of Glasgow team. A number of the scientific concepts detailed in this paper make up a critical part of DeepMatter's commercial strategy.

 

DeepMatter has used its own universal and interoperable standard for writing and sharing chemical recipes as part of its DigitalGlassware™ platform. Currently, the platform allows experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. It is designed to enable scientists to work together effectively, sharing the details of their experiments in real time from anywhere so that work is not needlessly duplicated, time and money wasted, and ultimately so that new discoveries may be made faster.

 

DeepMatter's long term goal is to use DigitalGlassware™ to control robotics and to ultimately progress towards a commercially viable Chemputer™. In 2017, as part of its strategy to build its commercial market presence for the digitization of chemistry, DeepMatter registered the trademark for the Chemputer™ brand.

 

The full scientific Paper, 'Organic synthesis in a modular robotic system driven by a chemical programming language' can be found at www.sciencemag.org

 

Mark Warne, CEO of DeepMatter, commented:

 

"We are very pleased to see the work of our founding scientific director published in Science today. The recognition of such an esteemed publication demonstrates the significance of both the University of Glasgow's important research and our work here at DeepMatter, translating these advances into a commercially viable strategy.

 

"We believe that these developments can truly disrupt the way in which process and discovery chemistry is carried out today, bringing huge financial benefits to those working in these industries. We are very pleased to have the first stage of the DigitalGlasswareTM launch underway and look forward to continuing to educate chemists worldwide as to the benefits of using the platform."

 

For further information:

 

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Stockdale Securities Limited

 

T: 020 7601 6100

Tom Griffiths

Edward Thomas

 

 

 

Alma PR

Caroline Forde

Rebecca Sanders-Hewett

Susie Hudson

 

T: 020 3405 0209

deepmatter@almapr.co.uk

 

About DeepMatter:

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

More information is available here: http://www.deepmattergroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPFNAELPFFF
Date   Source Headline
28th Aug 20209:05 amRNSSecond Price Monitoring Extn
28th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20208:54 amRNSHolding(s) in Company
11th Aug 20204:13 pmRNSHolding(s) in Company
6th Aug 202012:30 pmRNSHolding(s) in Company
29th Jul 202012:16 pmRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
23rd Jul 20209:59 amRNSHolding(s) in Company
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20205:11 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSResults of Placing
13th Jul 20207:00 amRNSPlacing and Subscription to raise £2.1 million
2nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20201:39 pmRNSResult of AGM and Directorate Change
4th Jun 20207:00 amRNSDigitalGlassware to Interface with Waters’ UNIFI
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSFinal Results
26th May 20207:00 amRNSNotice of Results and Investor Presentation
11th May 202011:57 amRNSHolding(s) in Company
1st May 20208:21 amRNSHolding(s) in Company
28th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSContract with Cancer Research UK Beatson Institute
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
12th Feb 20207:00 amRNSDeepMatter collaborates with University of Leeds
24th Jan 20207:00 amRNSChange of Adviser
21st Jan 20206:10 pmRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDeepMatter Appoints Industry Advisors
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 201911:05 amRNSSecond Price Monitoring Extn
9th Dec 201911:00 amRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSDeepMatter collaboration with AstraZeneca
19th Sep 20197:00 amRNSInterim Results
12th Aug 20197:00 amRNSLaunch of DigitalGlassware Online Portal
8th Aug 20197:00 amRNSFirst revenues for DigitalGlassware
3rd Jul 20192:55 pmRNSChange of Registered Address
28th Jun 20197:00 amRNSDirectorate Change
21st Jun 201912:34 pmRNSChange of Adviser
3rd Jun 20193:41 pmRNSHolding(s) in Company
22nd May 201911:19 amRNSResult of AGM
12th Apr 20197:01 amRNSBoard Changes & Appointments to Advisory Committee
12th Apr 20197:00 amRNSFinal Results
11th Apr 20195:12 pmRNSHolding(s) in Company
10th Apr 201912:58 pmRNSHolding(s) in Company
4th Apr 20193:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.